In transgenic MHC-CELFΔ mice, which express a dominant-negative CELF protein in the heart, impaired CELF activity leads to early-onset alternative splicing defects, resulting in cardiac hypertrophy, dilated cardiomyopathy, fibrosis, severe heart dysfunction, and premature death [27]. This evidence concerns the gene CEBPD and cardiac hypertrophy.